Latest Regulatory News

News Corporation has updated its dividend details for the six months ending June 2025, confirming an ordinary unfranked dividend of USD 0.10 per Class A non-voting common stock CDI, payable in both US and Australian dollars.

Paterson Resources has announced a $2 million capital raising via a placement and a non-renounceable entitlement offer, aimed at advancing its Grace Project in Western Australia. The offer includes new shares priced at $0.018 each and free attaching options, with proceeds earmarked for drilling, studies, and working capital.

Yancoal Australia Ltd reported a sharp 61% drop in net profit for the first half of 2025 amid falling coal prices and supply chain disruptions, despite a 15% rise in production. The company declared a fully franked interim dividend and is advancing strategic acquisitions and sustainability initiatives.

The Supreme Court of Western Australia has approved Gold Fields’ acquisition of Gold Road Resources via a scheme of arrangement, setting the stage for a significant consolidation in the gold mining sector.

The Queensland Government has postponed the suspension of The Star Gold Coast's casino licence until September 2026, extending regulatory oversight as the company continues remediation efforts.

Westpac Banking Corporation has announced a fully franked quarterly distribution of AUD 1.1616 per Capital Note 10, reflecting a 4.66% annualised yield based on current benchmark rates.

Westpac Banking Corporation announces a fully franked distribution of AUD 1.2140 per Westpac Capital Notes 9 for the quarter ending December 2025, reflecting a 4.87% annualised yield based on current market rates.

Memphasys Limited is intensifying its commercial push for Felix, an innovative automated sperm separation system for IVF, backed by a landmark Middle East partnership and a fresh capital raise to scale manufacturing and sales.

Liontown Resources reported a solid FY25 with A$298 million in revenue and positive EBITDA, setting the stage for a strategic underground transition in FY26 backed by a strengthened balance sheet and sustainability commitments.

Recce Pharmaceuticals has initiated patient dosing in its pivotal Phase 3 trial for diabetic foot infections in Indonesia, targeting a significant market with high diabetes prevalence. Interim results expected in early 2026 could accelerate regulatory approval and commercial launch.

Environmental Clean Technologies Limited (ECT) is set to acquire exclusive rights to Rice University’s innovative Flash Joule Heating technology, promising a breakthrough in PFAS soil remediation. The company also announces a $3 million capital raise to accelerate development and commercialisation.

Invex Therapeutics has voluntarily suspended trading on the ASX pending a significant acquisition announcement and responses to a price query. The suspension is expected to last until the announcement or early next week.